Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above

Benzer Materyaller

• Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial
  Yazar:: Heng Shen, ve diğerleri
  Baskı/Yayın Bilgisi: (2021-02-01)
• A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens
  Yazar:: Hua-Kun Lv, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-02-01)
• Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China
  Yazar:: Zhenzhen Liang, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-11-01)
• Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
  Yazar:: Jia Li, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-12-01)
• Rabies post-exposure prophylaxis in the emergency department: A monocentric retrospective observational study
  Yazar:: Mareen Braunstein, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)